COVID-19: transmission & prevention

Case report of COVID-19 transmission from sneezing cat

Herd immunity unlikely to control COVID-19: opinion article from US NIAID

Melatonin does not protect against SARS-CoV-2

Outbreak of 469 symptomatic Delta cases in fully vaccinated adults during Bear Week

US likely to have had SARS cases in December 2020

Selected presentations at BHIVA: COVID-19, PrEP in the UK, community involvement and more…

Asymptomatic infection has similar SARS-CoV-2 viral load to mild COVID-19

Correlation between COVID-19 severity and immune responses after six months

Durable antibody responses 9 months after exposure irrespective of symptoms: broader vaccine coverage still needed to reach herd immunity

Bar opening in the US: 100 guests linked to at least 46 cases of COVID-19

Large sporting event in US linked to 649 cases of COVID-19

Three carefully documented cases of SARS-CoV-2 transmission in a hospital setting despite masks

What are the main COVID-19 variants? How can they affect vaccine responses?

Hydroxychloroquine fails to prevent COVID-19 or SARS-CoV-2 transmission when used as PEP

Adverse pregnancy outcomes among Spanish women hospitalised with COVID-19

COVID-19 reinfection can occur after varying times and with more severe disease

Transmission from children to family members in US childcare setting

Infectious SARS-CoV-2 in air and on surfaces in London hospitals

US prisoners have higher mortality rates from COVID-19

US SARS-CoV-2 epidemic could see 100,000 cases per day: NIAID head Anthony Fauci to Senate hearing

Two PEP studies report no benefit of hydroxychloroquine for preventing CoV-2 infection

Coronavirus: the risks – know them – avoid them

Articles supporting wider use of face masks

COVID-19 prophylaxis using TDF/FTC and low-dose hydroxychloroquine in Spanish health workers

Four papers on CoV-2 transmission

Studies stoke concern about coronavirus contagion through air via speech

FDA reduces restrictions on gay men donating blood in the US due to COVID-19

CoV-2 identified in blood donations in China

COVID-19 vaccine study opens for recruitment in UK

US NIH vaccine chief optimistic on prospects for SARS-CoV-2 vaccine

Harm reduction for people who inject drugs and for people in prison

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

Median estimated incubation period of COVID-19 is five days – but can be two weeks

Selected epidemiology links and papers for COVID-19

Rapid and point of care testing for SARS-CoV-2

Peer-review articles on COVID-19 and pregnancy

Sex, HIV and STIs during COVID-19 pandemic